Article citationsMore>>

Hildebrandt, B., Drager, J., Kerner, T., Deja, M., Löffel, J., Stroszczynski, C., et al. (2004) Whole-Body Hyperthermia in the Scope of von Ardenne’s Systemic Cancer Multistep Therapy (sCMT) Combined with Chemotherapy in Patients with Metastatic Colorectal Cancer: A Phase I/II Study. International Journal of Hyperthermia, 20, 317-333.
http://dx.doi.org/10.1080/02656730310001637316

has been cited by the following article:

• TITLE: Generalization of the Thermal Dose of Hyperthermia in Oncology

  AUTHORS: Gyula Vincze, Oliver Szasz, Andras Szasz

  KEYWORDS: Thermal Dose, Oncothermia, Nano-Targeting

  JOURNAL NAME: Open Journal of Biophysics, Vol.5 No.4, October 28, 2015

  ABSTRACT: Hyperthermia has been a modality to treat cancer for thousands of years. During this time, intensive efforts are concentrated on determining the dose of the proper treatment, but the dominantly in vitro induced cellular death does not provide enough confidence for the clinical dosing. The cell-death by heat-monotherapy applications in laboratory experiments is difficult to apply in the complementary therapies in clinical applications. The newly developed nanotechnologies offer completely new possibilities in this field as well. Modulated electro-hyperthermia (mEHT, trade-name Oncothermia) is a nanoheating technology that has selective effects on membrane rafts and on the transmembrane proteins. This effect is thermal. The thermal action is in nanoscopic range which makes the phenomenon special. Our objective is to show the dose concept on this emerging method.